AI Screener Alert: FFAI Jumps 55% as EPS Revisions Spark Rally in 5 Stocks
FFAI led today's movers with a 54.5% surge after analysts raised its forward EPS estimate by 12.9 percentage points, while SPIR and CAR both gained 45.4% on strong earnings growth revisions. The healthcare sector contributed TLX (+23.1%) and SLNO (+33.3%), with all five stocks detected early by the EPS revision screener before price appreciation.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| FFAI | Consumer Cyclical | 2026-04-06 | +12.9pp | +54.5% |
| SPIR | Industrials | 2026-04-05 | +36.7pp | +45.4% |
| CAR | Industrials | 2026-04-06 | +4.1pp | +45.4% |
| SLNO | Healthcare | 2026-04-05 | +9.5pp | +33.3% |
| TLX | Healthcare | 2026-04-05 | +29.1pp | +23.1% |
Why did FFAI stock jump in April 2026?
FFAI jumped 54.5% (from $0.22 to $0.34) after analysts raised its forward EPS growth estimate from 50.3% to 63.2% on April 6, 2026.
The Consumer Cyclical EV maker saw increased confidence in its production ramp and cost structure improvements. The screener detected the revision before the bulk of the price appreciation occurred, allowing early subscribers to capture the move. No recent news catalysts were identified, suggesting the move was driven entirely by earnings estimate revisions.
View screener snapshot from 2026-04-06 →
FAQ: FFAI
Why did FFAI stock jump 55% in April 2026?
FFAI surged 54.5% after analysts revised its forward EPS growth estimate upward by 12.9 percentage points to 63.2% on April 6, 2026, reflecting improved profitability expectations for the EV maker.
Is FFAI a buy after the rally?
The 54.5% gain brings FFAI to $0.34, but analysts continue raising EPS targets, suggesting further upside potential if execution on production targets remains on track.
What caused FFAI's surge on April 13, 2026?
FFAI's surge was triggered by the EPS revision from 50.3% to 63.2% growth, with the screener detecting the upgrade on April 6 before the stock rallied to its current $0.34 level.
Why did SPIR stock jump in April 2026?
SPIR jumped 45.4% (from $15.91 to $23.14) after analysts raised its forward EPS growth estimate from 58.9% to 95.6% on April 5, 2026.
The space tech and satellite data company saw the largest percentage-point revision among today's movers at +36.7pp. No news catalysts were identified, indicating the market is pricing in stronger commercial contracts and data services revenue growth. The Industrials sector broadly benefited from renewed interest in infrastructure and orbital services.
View screener snapshot from 2026-04-05 →
FAQ: SPIR
Why did SPIR stock surge 45% this week?
SPIR surged 45.4% after analysts raised its forward EPS growth estimate from 58.9% to 95.6% on April 5, 2026—a 36.7 percentage point upgrade signaling strong expected growth in its satellite data and orbital services business.
What is SPIR's current EPS growth estimate?
SPIR's forward EPS growth estimate was revised to 95.6% from 58.9%, representing a 36.7 percentage point increase detected by the screener on April 5, 2026.
Is SPIR a buy after the rally?
SPIR trades at $23.14 after a 45.4% gain, but the dramatic EPS revision to 95.6% growth suggests the market may be undervaluing the company's satellite services pipeline.
Why did CAR stock jump in April 2026?
CAR jumped 45.4% (from $255.15 to $371.01) after analysts raised its forward EPS growth estimate from 100.6% to 104.7% on April 6, 2026.
Avis Budget Group benefits from strong travel demand recovery and improved fleet utilization in the Industrials sector. The stock moved despite no recent news catalysts, as investors anticipate stronger-than-expected travel season profitability. The screener caught the upgrade early in the move.
View screener snapshot from 2026-04-06 →
FAQ: CAR
Why did CAR stock jump 45% in April 2026?
CAR jumped 45.4% after analysts raised its forward EPS growth estimate from 100.6% to 104.7% on April 6, 2026, driven by expectations for strong travel season revenue and fleet pricing power.
What caused CAR's surge?
CAR's surge to $371.01 was triggered by an EPS revision from 100.6% to 104.7% growth, with the screener detecting the upgrade on April 6 before the stock appreciated 45.4%.
Is CAR a buy after the Avis Budget rally?
CAR at $371.01 reflects a 45.4% gain, but analyst EPS estimates continue rising toward 104.7% growth, suggesting the stock may have further room as travel demand remains robust.
Why did SLNO stock jump in April 2026?
SLNO jumped 33.3% (from $39.49 to $52.64) after analysts raised its forward EPS growth estimate from 59.2% to 68.7% on April 5, 2026.
The Healthcare biotech saw renewed investor interest in its therapeutic pipeline with no identified news catalysts. The 9.5 percentage point EPS revision suggests improved commercial prospects for its drug candidates. The screener identified the estimate change before today's price appreciation.
View screener snapshot from 2026-04-05 →
FAQ: SLNO
Why did SLNO stock surge 33% this week?
SLNO surged 33.3% after analysts raised its forward EPS growth estimate from 59.2% to 68.7% on April 5, 2026, reflecting improved commercial expectations for its therapeutic pipeline.
What caused SLNO's surge?
SLNO's rally to $52.64 was driven by a 9.5 percentage point EPS revision to 68.7% growth, detected by the screener on April 5 before the stock gained 33.3%.
What is SLNO's EPS growth estimate?
SLNO's forward EPS growth estimate was revised to 68.7% from 59.2%, a 9.5 percentage point increase detected early by the screener on April 5, 2026.
Why did TLX stock jump in April 2026?
TLX jumped 23.1% (from $9.13 to $11.24) after analysts raised its forward EPS growth estimate from 189.8% to 218.8% on April 5, 2026.
Telix Pharmaceuticals surged following its strategic radiopharma collaboration announcement with Regeneron, reinforcing the earnings growth trajectory. The Healthcare sector ADR saw the highest absolute EPS growth revision at +29.1 percentage points. The news catalyst combined with analyst estimate upgrades to drive sustained buying interest.
View screener snapshot from 2026-04-05 →
FAQ: TLX
Why did TLX stock jump 23% this week?
TLX jumped 23.1% after analysts raised its forward EPS growth estimate from 189.8% to 218.8% on April 5, 2026, coinciding with its strategic radiopharma collaboration announcement with Regeneron.
What caused TLX's surge?
TLX's surge to $11.24 was triggered by a 29.1 percentage point EPS revision combined with the Regeneron collaboration news, with the screener detecting the upgrade on April 5.
Is TLX a buy after the rally?
TLX at $11.24 reflects a 23.1% gain, and with EPS growth estimates now at 218.8%, the Regeneron partnership may provide catalysts for further upside in the radiopharma space.
Today's movers demonstrate that EPS revision screenings effectively identify early-stage price appreciation opportunities, with growth estimate upgrades ranging from 4.1 to 36.7 percentage points translating into 23-55% stock gains. Healthcare stocks (TLX, SLNO) showed the highest EPS growth rates, while Industrials (SPIR, CAR) benefited from sector momentum in space tech and travel services.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →